Sector: Medical
Industry: Medical-Biomed & Genetics
3-Year Growth Rate: 11,839%
2015 Revenue: $130,014,000
2012 Revenue: $1,089,000
Stock Ticker: LXRX
Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomic technologies to accelerate large-scale analysis of mammalian gene function for drug discovery.
